American biggies are joining hands with Chinese companies. AbbVie signed a deal with Simcere Zaiming for a multiple myeloma ...

India’s Contract Development and Manufacturing Organization (CDMO) market is witnessing a strong growth trajectory driven by ...

Indian pharma companies are expanding in the US through acquisitions to navigate regulations, diversify portfolios, and ...

A study found Indian generics sold in the US between 2009-2018 linked to a 54% higher risk of serious side effects compared ...

Sun Pharmaceutical Industries—controlled by Indian billionaire Dilip Shanghvi—has agreed to buy U.S.-based immunotherapy and ...

Dilip Shanghvi, chairman of India's largest drugmaker Sun Pharma, told an industry gathering last week that his company sells ...

The Indian Pharmaceutical Alliance refutes a study claiming Indian generic drugs have higher adverse events, stating quality ...

Pharma stocks are down, but is this a golden buying opportunity? With India's booming sector and low P/E stocks in focus, ...

Introduction of a direct-to-patient delivery model for its weight-loss drug in the United States could potentially delay its ...

India's Sun Pharmaceutical Industries said on Monday it will acquire Checkpoint Therapeutics, a U.S.-based immunotherapy and ...

A new study reveals that generic drugs made in India are linked to a significantly higher number of severe adverse events, ...